Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Injectable Hydrogels: From Laboratory to Industrialization.

Tytuł:
Injectable Hydrogels: From Laboratory to Industrialization.
Autorzy:
Alonso JM; I+Med. S. Coop., Parque Tecnológico de Alava. Albert Einstein 15, Nave 15, 01510 Vitoria-Gasteiz, Spain.
Andrade Del Olmo J; I+Med. S. Coop., Parque Tecnológico de Alava. Albert Einstein 15, Nave 15, 01510 Vitoria-Gasteiz, Spain.
Perez Gonzalez R; I+Med. S. Coop., Parque Tecnológico de Alava. Albert Einstein 15, Nave 15, 01510 Vitoria-Gasteiz, Spain.
Saez-Martinez V; I+Med. S. Coop., Parque Tecnológico de Alava. Albert Einstein 15, Nave 15, 01510 Vitoria-Gasteiz, Spain.
Źródło:
Polymers [Polymers (Basel)] 2021 Feb 22; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 22.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Basel : MDPI
References:
Anal Chem. 2011 Jun 15;83(12):4453-88. (PMID: 21545140)
J Control Release. 2020 Oct 10;326:150-163. (PMID: 32562854)
J Biomater Appl. 2012 Feb;26(6):745-59. (PMID: 21123283)
Int J Biol Macromol. 2019 May 15;129:233-245. (PMID: 30738157)
J Mater Chem B. 2019 Apr 7;7(13):2151-2161. (PMID: 32073574)
Int J Mol Sci. 2012;13(9):11194-11209. (PMID: 23109847)
Expert Rev Med Devices. 2017 Feb;14(2):161-167. (PMID: 28080154)
Carbohydr Polym. 2017 Feb 10;157:1525-1530. (PMID: 27987864)
Biomacromolecules. 2004 Jul-Aug;5(4):1280-7. (PMID: 15244441)
Carbohydr Polym. 2019 Jan 1;203:349-355. (PMID: 30318222)
Nat Protoc. 2017 Aug;12(8):1521-1541. (PMID: 28683063)
Int J Biol Macromol. 2009 Mar 1;44(2):121-7. (PMID: 19041888)
Adv Drug Deliv Rev. 2002 Jan 17;54(1):3-12. (PMID: 11755703)
Eur Polym J. 2015 Nov 1;72:566-576. (PMID: 26688592)
Biomacromolecules. 2019 Apr 8;20(4):1478-1492. (PMID: 30843390)
Carbohydr Polym. 2013 Feb 15;92(2):1262-79. (PMID: 23399155)
ACS Appl Mater Interfaces. 2016 Oct 26;8(42):28511-28521. (PMID: 27704757)
Mater Sci Eng C Mater Biol Appl. 2014 May 1;38:177-85. (PMID: 24656366)
Carbohydr Polym. 2015 Oct 20;131:407-14. (PMID: 26256201)
Biomater Sci. 2018 Sep 25;6(10):2627-2638. (PMID: 30109875)
Soft Matter. 2018 Oct 3;14(38):7809-7817. (PMID: 30074040)
Int J Biol Macromol. 2020 Nov 1;162:781-797. (PMID: 32553980)
AAPS J. 2014 Jul;16(4):771-83. (PMID: 24854893)
Curr Eye Res. 2017 Apr;42(4):498-505. (PMID: 27610546)
J Biomater Sci Polym Ed. 2017 Jun;28(8):794-805. (PMID: 28278043)
Macromolecules. 2010 Aug 24;43(16):6861-6870. (PMID: 21403767)
Acc Chem Res. 2019 Aug 20;52(8):2101-2112. (PMID: 31291090)
Polymers (Basel). 2020 Mar 05;12(3):. (PMID: 32150859)
Macromol Rapid Commun. 2016 Dec;37(23):1881-1896. (PMID: 27753168)
Int J Biol Macromol. 2018 Oct 15;118(Pt A):1257-1266. (PMID: 30021396)
Biomacromolecules. 2002 May-Jun;3(3):511-6. (PMID: 12005522)
J Mater Sci Mater Med. 2018 Jun 14;29(6):88. (PMID: 29904797)
Drug Deliv Transl Res. 2020 Jun;10(3):621-634. (PMID: 32040775)
Adv Healthc Mater. 2020 Feb;9(4):e1901134. (PMID: 31943865)
Macromol Biosci. 2009 Jan 9;9(1):20-8. (PMID: 18839402)
Biomacromolecules. 2019 Jan 14;20(1):149-163. (PMID: 30376309)
Biomaterials. 2012 Mar;33(7):2145-53. (PMID: 22177842)
Carbohydr Polym. 2020 Nov 15;248:116811. (PMID: 32919543)
Int J Pharm. 2020 Jan 5;573:118803. (PMID: 31682963)
Biomaterials. 2014 Apr;35(12):3903-17. (PMID: 24507411)
J Drugs Dermatol. 2011 Sep;10(9):974-80. (PMID: 22052265)
Polymers (Basel). 2020 Oct 01;12(10):. (PMID: 33019575)
J Biomed Mater Res B Appl Biomater. 2014 Jul;102(5):1063-73. (PMID: 24357498)
J Mater Sci Mater Med. 2020 Jul 21;31(8):64. (PMID: 32696261)
Trends Biotechnol. 2020 Jun;38(6):579-583. (PMID: 31926600)
Int J Nanomedicine. 2018 Oct 15;13:6453-6463. (PMID: 30410331)
Carbohydr Polym. 2018 Apr 15;186:82-90. (PMID: 29456012)
Biomacromolecules. 2012 Dec 10;13(12):3966-76. (PMID: 23151204)
Artif Cells Nanomed Biotechnol. 2018;46(sup2):874-882. (PMID: 29749265)
Chem Rev. 2011 Aug 10;111(8):4453-74. (PMID: 21417222)
Polymers (Basel). 2019 Apr 24;11(4):. (PMID: 31022975)
Prog Polym Sci. 2019 Apr;91:126-140. (PMID: 31571701)
Biomater Sci. 2019 Oct 1;7(10):4195-4207. (PMID: 31386700)
Biomater Res. 2018 Sep 26;22:27. (PMID: 30275970)
Carbohydr Polym. 2019 May 15;212:242-251. (PMID: 30832854)
J Microbiol Biotechnol. 2015 Mar;25(3):399-406. (PMID: 25502824)
J Plast Reconstr Aesthet Surg. 2009 Jan;62(1):11-8. (PMID: 18951862)
RSC Adv. 2020 Jan 15;10(5):2870-2876. (PMID: 35496102)
Contributed Indexing:
Keywords: hydrogels; industrialization; injectable; polysaccharides; regulation; scale-up
Entry Date(s):
Date Created: 20210306 Latest Revision: 20240331
Update Code:
20240331
PubMed Central ID:
PMC7926321
DOI:
10.3390/polym13040650
PMID:
33671648
Czasopismo naukowe
The transfer of some innovative technologies from the laboratory to industrial scale is many times not taken into account in the design and development of some functional materials such as hydrogels to be applied in the biomedical field. There is a lack of knowledge in the scientific field where many aspects of scaling to an industrial process are ignored, and products cannot reach the market. Injectable hydrogels are a good example that we have used in our research to show the different steps needed to follow to get a product in the market based on them. From synthesis and process validation to characterization techniques used and assays performed to ensure the safety and efficacy of the product, following regulation, several well-defined protocols must be adopted. Therefore, this paper summarized all these aspects due to the lack of knowledge that exists about the industrialization of injectable products with the great importance that it entails, and it is intended to serve as a guide on this area to non-initiated scientists. More concretely, in this work, the characteristics and requirements for the development of injectable hydrogels from the laboratory to industrial scale is presented in terms of (i) synthesis techniques employed to obtain injectable hydrogels with tunable desired properties, (ii) the most common characterization techniques to characterize hydrogels, and (iii) the necessary safety and efficacy assays and protocols to industrialize and commercialize injectable hydrogels from the regulatory point of view. Finally, this review also mentioned and explained a real example of the development of a natural hyaluronic acid hydrogel that reached the market as an injectable product.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies